WallStSmart

Syntec Optics Holdings Inc. (OPTX)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 822% more annual revenue ($258.90M vs $28.08M). OPTX leads profitability with a -6.4% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

OPTX

Avoid

13

out of 100

Grade: F

Growth: 3.3Profit: 2.5Value: 4.0Quality: 4.0
Piotroski: 1/9Altman Z: 1.91

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

OPTXSignificantly Overvalued (-76.9%)

Margin of Safety

-76.9%

Fair Value

$3.51

Current Price

$7.67

$4.16 premium

UndervaluedFair: $3.51Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

OPTX0 strengths · Avg: 0/10

No standout strengths identified

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

OPTX4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
2.5%4/10

2.5% revenue growth

Altman Z-ScoreHealth
1.914/10

Grey zone — moderate risk

Market CapQuality
$347.75M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.3%3/10

Operating margin of 4.3%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : OPTX

OPTX has a balanced fundamental profile.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : OPTX

The primary concerns for OPTX are Revenue Growth, Altman Z-Score, Market Cap.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

OPTX profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 13/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Syntec Optics Holdings Inc.

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Syntec Optics Holdings Inc. (OTC: OPTX) is a prominent provider of sophisticated optical solutions, specializing in the design and manufacturing of high-precision optical components for sectors including medical, aerospace, and telecommunications. The company's dedication to cutting-edge technology and continuous research and development enables it to deliver innovative products that meet the dynamic demands of its diverse clientele. With a strategic focus on sustainability and operational excellence, Syntec Optics is poised to capitalize on significant growth opportunities within the expanding optical market, driven by a rising global demand for advanced optical technologies.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?